Featured Research

from universities, journals, and other organizations

Study finds similar outcomes for repair or replacement of damaged heart valves

Date:
November 18, 2013
Source:
University of Pennsylvania School of Medicine
Summary:
New research has found no difference in outcomes at one-year between two recommended surgical options for treating ischemic mitral regurgitation -- repair of the leaky valve or its replacement with an artificial valve.

New research presented at the 2013 Scientific Sessions of the American Heart Association by researchers at the Perelman School of Medicine at the University of Pennsylvania found no difference in outcomes at one-year between two recommended surgical options for treating ischemic mitral regurgitation (IMR) -- repair of the leaky valve or its replacement with an artificial valve. The study, conducted by the Cardiothoracic Surgical Trials Network (CTSN), a consortium supported by the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS) of the National Institute of Health, along with the Canadian Institutes of Health Research (CIHR), was published simultaneously in the New England Journal of Medicine.

Mitral regurgitation -- where blood flows backwards toward the lungs during the contraction of the heart instead of forwards -- affects millions of people in the U.S. and can pose serious health consequences, most prominently ongoing and worsening heart failure. Guidelines currently recommend either repair or replacement of severe mitral leak caused by ischemic mitral insufficiency when medical alternatives have failed.

"While the medical community has traditionally gravitated towards valve repair as a preferred treatment option, the evidence in this study does not suggest that mitral valve repair is superior," said lead study author Michael Acker, MD, chief, Division of Cardiovascular Surgery and director, Penn Medicine Heart and Vascular Center. "Further patient follow-up is needed to confirm the findings of this trial, but we believe these results should be very helpful for cardiologists and surgeons in choosing an appropriate approach for this growing patient population."

This multi-center study, the Severe MR randomized trial (of which cardiac surgeons at Pennwere the leading enrollers), is the first randomized clinical trial comparing these two options to treat IMR. Both approaches offer benefits and risks, but as of yet no study has rigorously evaluated these approaches to see if the trade-offs result in significant differences in patient outcomes.

The study enrolled 251 patients who were diagnosed with IMR, which is due to a valve deformation that occurs after a heart attack. The participants were evenly randomized to receive either surgical repair (a valve tightening procedure called an annuloplasty) or a prosthetic replacement mitral valve.

The participants were then monitored at one, six, and 12 months after their procedure. The primary endpoint of the study was the degree of left ventricular shrinkage (reverse remodeling) which correlates to improvement in heart function and the lessening of heart failure symptoms. The study also measured various health outcomes, including rates of death, recurrent mitral valve leak, severe heart problems or stroke, re-hospitalizations, and quality of life.

After a year a follow-up, there were almost no differences in ventricle shrinkage or health between the two treatments. The only significant change was a higher rate of recurrent regurgitation in the repair group (32.6 percent of repair patients versus 2.3 percent of replacement patients).

"The increased level of recurrent regurgitation falls in line with valve replacement offering more durable long-term protection," noted Annetine Gelijns, Ph.D., CTSN investigator at the Icahn School of Medicine at Mount Sinai and corresponding author of the study. "However, these regurgitations did not lead to any noticeable increases of health problems among patients in the repair group."

The study investigators will continue to monitor the participants for 12 more month, as well as an analysis of predictors of recurrent mitral valve leak, which may help identify patient groups better suited for repair or replacement.


Story Source:

The above story is based on materials provided by University of Pennsylvania School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Michael A. Acker, Michael K. Parides, Louis P. Perrault, Alan J. Moskowitz, Annetine C. Gelijns, Pierre Voisine, Peter K. Smith, Judy W. Hung, Eugene H. Blackstone, John D. Puskas, Michael Argenziano, James S. Gammie, Michael Mack, Deborah D. Ascheim, Emilia Bagiella, Ellen G. Moquete, T. Bruce Ferguson, Keith A. Horvath, Nancy L. Geller, Marissa A. Miller, Y. Joseph Woo, David A. D'Alessandro, Gorav Ailawadi, Francois Dagenais, Timothy J. Gardner, Patrick T. O'Gara, Robert E. Michler, Irving L. Kron. Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. New England Journal of Medicine, 2013; 131118084523001 DOI: 10.1056/NEJMoa1312808

Cite This Page:

University of Pennsylvania School of Medicine. "Study finds similar outcomes for repair or replacement of damaged heart valves." ScienceDaily. ScienceDaily, 18 November 2013. <www.sciencedaily.com/releases/2013/11/131118160035.htm>.
University of Pennsylvania School of Medicine. (2013, November 18). Study finds similar outcomes for repair or replacement of damaged heart valves. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2013/11/131118160035.htm
University of Pennsylvania School of Medicine. "Study finds similar outcomes for repair or replacement of damaged heart valves." ScienceDaily. www.sciencedaily.com/releases/2013/11/131118160035.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins